theophylline has been researched along with salmeterol xinafoate in 58 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 27 (46.55) | 18.2507 |
2000's | 24 (41.38) | 29.6817 |
2010's | 7 (12.07) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL | 1 |
Bellows, DS; Clarke, ID; Diamandis, P; Dirks, PB; Graham, J; Jamieson, LG; Ling, EK; Sacher, AG; Tyers, M; Ward, RJ; Wildenhain, J | 1 |
García-Mera, X; González-Díaz, H; Prado-Prado, FJ | 1 |
Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
Bons, J; Pappo, M | 1 |
Georges, D; Muir, JF | 1 |
Bertin, L; Georges, D; Muir, JF | 1 |
Fjellbirkeland, L; Gulsvik, A; Palmer, JB | 1 |
Bayliss, MK; Eddershaw, PJ; Herriott, D; Manchee, GR; Park, GR; Ranshaw, LE; Tarbit, MH | 1 |
Di Franco, A; Giannini, D; Paggiaro, PL; Testi, R | 1 |
Adalioğlu, G; Saraçlar, Y; Tomaç, N; Tuncer, A | 1 |
Douglas, NJ; Engleman, HM; Fitzpatrick, MF; Mackay, TW; Selby, C; Sime, PM | 1 |
Kleerup, EC | 1 |
Cox, FM; Emmett, A; Pollard, SJ; Spector, SL; Yancey, SW | 1 |
Braun, H; Koper, I; Leutz, M; Schlimmer, P; Sybrecht, GW; Ukena, D | 1 |
Jick, H; Meier, CR | 1 |
Amsler, B; Hammer, J; Newth, CJ; Richardson, BP | 1 |
Nelson, HS | 1 |
Ukena, D | 2 |
Brooks, G; Davies, B; Devoy, M | 1 |
Martini, T; Nutini, S; Righi, R | 1 |
Cheung, D; de GOEIJ, JA; de GRAAFF, CS; Steen, H; Sterk, PJ; Wever, AM | 1 |
Lanes, SF; Lanza, LL; Wentworth, CE | 1 |
Altieri, E; Bousquet, J; Chanez, P; Chiappara, G; Gagliardo, R; Godard, P; Térouanne, B; Vachier, I; Vic, P; Vignola, AM | 1 |
Boichot, E; Escofier, N; Germain, N; Lagente, V; Martins, MA; Silva, PM | 1 |
Li, JT | 1 |
Mende, CN; Petrocella, VJ; Rickard, KA; Wiegand, L; Yancey, SW; Zaidel, G; Zwillich, CW | 1 |
Eid, N; Goldsmith, LJ; Howell, L; Sheikh, S | 1 |
Bancalari, L; Ghignoni, G; Paggiaro, PL; Taccola, M | 1 |
Coughlan, J; Gibson, PG; Wilson, AJ | 1 |
Calderaro, F; Cazzola, M; Centanni, S; Di Lorenzo, G; Di Perna, F; Testi, R | 1 |
Hendeles, L; Sherman, J | 1 |
Bousquet, J; Chanez, P; Chavis, C; Farce, M; Godard, P; Majori, M; Vachier, I | 1 |
Lipworth, BJ | 1 |
Church, N; Emmett, A; Knobil, K; Mahler, DA; Reilly, D; Rickard, K; ZuWallack, RL | 1 |
Jarvis, B; Markham, A | 1 |
Gibbs, BF; Grabbe, J; Plath, KE; Wolff, HH | 1 |
Colosimo, M; De Sarro, GB; Ferreri, G; Flocco, MA; Gallelli, L; Maselli, R; Pelaia, G; Pirritano, D | 1 |
Khamis, RY; Rajakulasingam, RK | 1 |
Dashash, NA; Mukhtar, SH | 1 |
Dal Negro, RW; Micheletto, C; Pomari, C; Tognella, S | 1 |
Devillier, P | 1 |
Fukkuda, T | 1 |
Bates, CE; Cowan, LM; Currie, GP; Lee, DK; Lipworth, BJ; McFarlane, LC | 1 |
Cazzola, M; Parrella, R; Pelaia, G; Ponticiello, A; Vatrella, A | 1 |
Broseghini, C; Polese, G; Rossi, A; Testi, R; Tosatto, R | 1 |
Aizawa, H; Fukuyama, S; Inoue, H; Kanaya, A; Komori, M; Matsumoto, K; Matsumoto, T; Matsumura, M; Moriwaki, A; Nakanishi, Y; Nakano, T; Tsuda, M; Yoshida, M | 1 |
Belfer, MH; Chapman, KR; Doherty, DE; Martinez, FJ | 1 |
Adachi, M; Aizawa, H; Ishihara, K; Nakashima, M; Ohta, K; Sano, Y; Taniguchi, H | 1 |
Aaron, SD; Fitzgerald, JM; Jones, PW; Marra, CA; Najafzadeh, M; Sadatsafavi, M; Sullivan, SD; Vandemheen, KL | 1 |
Kim, TS; Lim, SY; Park, HK; Park, HY; Park, SY; Suh, GY | 1 |
Nishima, S | 1 |
Clausen, T; Fredsted, A; Gissel, H; Ortenblad, N | 1 |
Matsuoka, S; Mineshita, M; Miyazawa, T | 1 |
10 review(s) available for theophylline and salmeterol xinafoate
Article | Year |
---|---|
Bronchodilators: new drugs and controversies.
Topics: Adrenal Cortex Hormones; Adrenergic beta-Agonists; Albuterol; Asthma; Asthma, Exercise-Induced; Bronchoconstriction; Bronchodilator Agents; Drug Monitoring; Humans; Phosphodiesterase Inhibitors; Receptors, Adrenergic, beta-2; Salmeterol Xinafoate; Theophylline | 1997 |
New developments in bronchodilator therapy.
Topics: Administration, Inhalation; Administration, Oral; Adrenal Cortex Hormones; Adrenergic beta-Agonists; Albuterol; Asthma; Biopsy; Bronchi; Bronchodilator Agents; Cause of Death; Cytokines; Drug Combinations; Eosinophils; Fenoterol; Humans; Lymphocytes; Quality of Life; Risk Factors; Salmeterol Xinafoate; Theophylline | 1996 |
The efficacy and safety of salmeterol compared to theophylline: meta-analysis of nine controlled studies.
Topics: Adrenergic beta-Agonists; Adult; Aged; Albuterol; Asthma; Bronchodilator Agents; Chronic Disease; Female; Humans; Male; Middle Aged; Peak Expiratory Flow Rate; Randomized Controlled Trials as Topic; Salmeterol Xinafoate; Theophylline | 1998 |
Long acting beta-agonists versus theophylline for maintenance treatment of asthma.
Topics: Adrenergic beta-Agonists; Adult; Albuterol; Asthma; Bronchodilator Agents; Delayed-Action Preparations; Humans; Salmeterol Xinafoate; Theophylline | 2000 |
Inhaled salmeterol: a review of its efficacy in chronic obstructive pulmonary disease.
Topics: Administration, Inhalation; Adrenergic beta-Agonists; Albuterol; Bronchodilator Agents; Cardiovascular System; Databases, Bibliographic; Drug Administration Schedule; Drug Therapy, Combination; Exercise Test; Female; Forced Expiratory Volume; Humans; Ipratropium; Lung Diseases, Obstructive; Male; Middle Aged; Quality of Life; Salmeterol Xinafoate; Theophylline | 2001 |
[Physiopathology of COPD: choosing the right therapeutic targets].
Topics: Adrenal Cortex Hormones; Aged; Albuterol; Animals; Bacterial Infections; Bronchodilator Agents; Carboxylic Acids; Cyclohexanecarboxylic Acids; Disease Models, Animal; Drug Therapy, Combination; Humans; Inflammation; Mucociliary Clearance; Nitriles; Phosphodiesterase Inhibitors; Pulmonary Alveoli; Pulmonary Disease, Chronic Obstructive; Pulmonary Emphysema; Randomized Controlled Trials as Topic; Rats; Rolipram; Salmeterol Xinafoate; Smoking; Theophylline; Time Factors | 2003 |
[Recent study on pathogenesis of bronchial asthma and the therapeutic strategy].
Topics: Administration, Inhalation; Adrenergic beta-Agonists; Albuterol; Anti-Asthmatic Agents; Anti-Inflammatory Agents; Asthma; Beclomethasone; Bronchi; Bronchial Diseases; Bronchial Hyperreactivity; Bronchitis; Constriction, Pathologic; Drug Therapy, Combination; Eosinophilia; Glucocorticoids; Humans; Salmeterol Xinafoate; Theophylline | 2004 |
[Asthma therapy: combination of topical glucocorticosteroids and theophylline].
Topics: Administration, Inhalation; Adrenergic beta-Agonists; Albuterol; Anti-Inflammatory Agents; Asthma; Beclomethasone; Bronchodilator Agents; Budesonide; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Glucocorticoids; Humans; Male; Multicenter Studies as Topic; Peak Expiratory Flow Rate; Randomized Controlled Trials as Topic; Salmeterol Xinafoate; Theophylline | 1997 |
[Bronchial asthma in children].
Topics: Administration, Inhalation; Adrenal Cortex Hormones; Adrenergic beta-Agonists; Albuterol; Androstadienes; Asthma; Asthma, Exercise-Induced; Child; Child, Preschool; Delayed-Action Preparations; Drug Combinations; Fluticasone; Humans; Infant; Leukotriene Antagonists; Nebulizers and Vaporizers; Salmeterol Xinafoate; Severity of Illness Index; Theophylline | 2011 |
Chronic obstructive pulmonary disease: Useful medications for patients with recurrent symptoms.
Topics: Administration, Inhalation; Adrenal Cortex Hormones; Adrenergic beta-2 Receptor Agonists; Aminopyridines; Benzamides; Bronchodilator Agents; Budesonide; Cyclopropanes; Fluticasone; Formoterol Fumarate; Humans; Ipratropium; Muscarinic Antagonists; Phosphodiesterase 4 Inhibitors; Pulmonary Disease, Chronic Obstructive; Recurrence; Salmeterol Xinafoate; Theophylline; Tiotropium Bromide | 2016 |
25 trial(s) available for theophylline and salmeterol xinafoate
Article | Year |
---|---|
[Salmeterol and prolonged treatment of asthma: international clinical data].
Topics: Adolescent; Adrenergic beta-Agonists; Adult; Aged; Albuterol; Asthma; Double-Blind Method; Drug Tolerance; Humans; Middle Aged; Respiratory Function Tests; Salmeterol Xinafoate; Theophylline; Time Factors | 1992 |
[Usefulness of salmeterol in nocturnal asthma: a comparative study with theophylline-ketotifen association. A French multicenter group].
Topics: Adolescent; Adrenergic beta-Agonists; Adult; Aged; Albuterol; Asthma; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Ketotifen; Male; Middle Aged; Salmeterol Xinafoate; Theophylline; Time Factors | 1992 |
Salmeterol versus slow-release theophylline combined with ketotifen in nocturnal asthma: a multicentre trial. French Multicentre Study Group.
Topics: Administration, Inhalation; Administration, Oral; Adolescent; Adult; Aged; Albuterol; Asthma; Bronchodilator Agents; Circadian Rhythm; Delayed-Action Preparations; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Ketotifen; Male; Middle Aged; Salmeterol Xinafoate; Theophylline | 1992 |
The efficacy and tolerability of inhaled salmeterol and individually dose-titrated, sustained-release theophylline in patients with reversible airways disease.
Topics: Administration, Inhalation; Adrenergic beta-Agonists; Albuterol; Asthma; Bronchodilator Agents; Cross-Over Studies; Delayed-Action Preparations; Double-Blind Method; Humans; Salmeterol Xinafoate; Theophylline | 1994 |
Comparison of inhaled salmeterol and individually dose-titrated slow-release theophylline in patients with reversible airway obstruction. European Study Group.
Topics: Administration, Inhalation; Administration, Oral; Adolescent; Adrenergic beta-Antagonists; Adult; Aged; Albuterol; Asthma; Bronchodilator Agents; Delayed-Action Preparations; Europe; Female; Humans; Male; Middle Aged; Multivariate Analysis; Respiratory Function Tests; Salmeterol Xinafoate; Theophylline; Treatment Outcome | 1996 |
Efficacy of salmeterol in the treatment of childhood asthma.
Topics: Adolescent; Adrenergic beta-Agonists; Airway Resistance; Albuterol; Asthma; Bronchodilator Agents; Child; Female; Humans; Longitudinal Studies; Male; Plethysmography, Whole Body; Respiratory Function Tests; Salmeterol Xinafoate; Theophylline; Time Factors | 1996 |
Inhaled salmeterol or oral theophylline in nocturnal asthma?
Topics: Administration, Inhalation; Administration, Oral; Adrenergic beta-Agonists; Adult; Aged; Albuterol; Asthma; Bronchodilator Agents; Cognition; Cross-Over Studies; Double-Blind Method; Female; Humans; Male; Middle Aged; Peak Expiratory Flow Rate; Salmeterol Xinafoate; Sleep; Theophylline; Vital Capacity | 1997 |
Salmeterol versus theophylline in the treatment of asthma.
Topics: Administration, Inhalation; Adolescent; Adrenergic beta-Agonists; Adult; Aged; Aged, 80 and over; Albuterol; Asthma; Bronchodilator Agents; Dose-Response Relationship, Drug; Female; Headache; Humans; Male; Middle Aged; Patient Satisfaction; Respiratory Function Tests; Salmeterol Xinafoate; Surveys and Questionnaires; Theophylline | 1997 |
[Therapy of nocturnal asthma: salmeterol versus nocturnal administration of retard theophylline--comparison of effectiveness and tolerance].
Topics: Adult; Albuterol; Asthma; Bronchodilator Agents; Cross-Over Studies; Delayed-Action Preparations; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Female; Forced Expiratory Volume; Humans; Male; Middle Aged; Salmeterol Xinafoate; Sleep Wake Disorders; Theophylline | 1997 |
[Inhaled salmeterol or oral theophylline in nocturnal asthma?].
Topics: Administration, Inhalation; Administration, Oral; Albuterol; Asthma; Bronchodilator Agents; Cross-Over Studies; Double-Blind Method; Humans; Salmeterol Xinafoate; Sleep Wake Disorders; Theophylline | 1997 |
Long-term treatment of asthmatic patients with salmeterol vs slow-release theophylline.
Topics: Administration, Inhalation; Adrenergic beta-Agonists; Albuterol; Asthma; Bronchodilator Agents; Delayed-Action Preparations; Female; Forced Expiratory Volume; Humans; Lung; Male; Middle Aged; Peak Expiratory Flow Rate; Salmeterol Xinafoate; Theophylline | 1998 |
Effects of theophylline on tolerance to the bronchoprotective actions of salmeterol in asthmatics in vivo.
Topics: Administration, Inhalation; Adrenergic beta-Agonists; Adult; Albuterol; Asthma; Bronchi; Bronchial Provocation Tests; Bronchoconstriction; Bronchodilator Agents; Double-Blind Method; Down-Regulation; Drug Interactions; Drug Tolerance; Female; Forced Expiratory Volume; Histamine; Humans; Male; Middle Aged; Placebos; Salmeterol Xinafoate; Theophylline | 1998 |
Salmeterol vs theophylline: sleep and efficacy outcomes in patients with nocturnal asthma.
Topics: Administration, Inhalation; Adolescent; Adrenergic beta-Agonists; Adult; Albuterol; Asthma; Bronchodilator Agents; Circadian Rhythm; Cross-Over Studies; Delayed-Action Preparations; Double-Blind Method; Female; Follow-Up Studies; Humans; Male; Respiratory Function Tests; Safety; Salmeterol Xinafoate; Sleep; Theophylline; Treatment Outcome | 1999 |
Comparison of the efficacy of inhaled fluticasone propionate, 880 microg/day, with flunisolide, 1500 microg/day, in moderate-to-severe persistent asthma.
Topics: Absenteeism; Administration, Inhalation; Adolescent; Albuterol; Androstadienes; Asthma; Child; Cross-Over Studies; Drug Therapy, Combination; Emergencies; Female; Fluocinolone Acetonide; Fluticasone; Follow-Up Studies; Hospitalization; Humans; Male; Nebulizers and Vaporizers; Pulmonary Ventilation; Salmeterol Xinafoate; Seasons; Spirometry; Theophylline; Treatment Outcome | 1999 |
Salmeterol versus slow-release theophylline in patients with reversible obstructive pulmonary disease.
Topics: Adrenergic beta-Agonists; Albuterol; Bronchodilator Agents; Delayed-Action Preparations; Humans; Lung Diseases, Obstructive; Respiratory Function Tests; Salmeterol Xinafoate; Theophylline; Treatment Outcome | 1999 |
Additive effects of salmeterol and fluticasone or theophylline in COPD.
Topics: Administration, Inhalation; Adrenergic beta-Agonists; Aged; Albuterol; Androstadienes; Bronchodilator Agents; Dose-Response Relationship, Drug; Drug Synergism; Drug Therapy, Combination; Female; Fluticasone; Forced Expiratory Volume; Glucocorticoids; Humans; Lung Diseases, Obstructive; Male; Middle Aged; Salmeterol Xinafoate; Theophylline | 2000 |
Salmeterol plus theophylline combination therapy in the treatment of COPD.
Topics: Adrenergic beta-Agonists; Aged; Aged, 80 and over; Albuterol; Bronchodilator Agents; Double-Blind Method; Drug Therapy, Combination; Female; Hemodynamics; Humans; Lung Diseases, Obstructive; Male; Middle Aged; Salmeterol Xinafoate; Theophylline | 2001 |
Salmeterol & fluticasone 50 microg/250 microg bid in combination provides a better long-term control than salmeterol 50 microg bid alone and placebo in COPD patients already treated with theophylline.
Topics: Aged; Albuterol; Analysis of Variance; Androstadienes; Bronchodilator Agents; Double-Blind Method; Drug Therapy, Combination; Female; Fluticasone; Humans; Male; Maximal Expiratory Flow Rate; Middle Aged; Pilot Projects; Pulmonary Disease, Chronic Obstructive; Salmeterol Xinafoate; Theophylline | 2003 |
Effects of high-dose inhaled fluticasone propionate on the hypothalamic-pituitary-adrenal axis in asthmatic patients with severely impaired lung function.
Topics: Adult; Albuterol; Androstadienes; Anti-Asthmatic Agents; Asthma; Beclomethasone; Blood Proteins; Breath Tests; Creatinine; Dose-Response Relationship, Drug; Drug Therapy, Combination; Eosinophil Granule Proteins; Ethanolamines; Female; Fluticasone; Forced Expiratory Volume; Formoterol Fumarate; Humans; Hydrocortisone; Hypothalamo-Hypophyseal System; Male; Metered Dose Inhalers; Nitric Oxide; Peak Expiratory Flow Rate; Pituitary-Adrenal System; Ribonucleases; Salmeterol Xinafoate; Theophylline | 2004 |
Bronchodilating effects of salmeterol, theophylline and their combination in patients with moderate to severe asthma.
Topics: Administration, Oral; Adult; Albuterol; Asthma; Bronchodilator Agents; Cross-Over Studies; Delayed-Action Preparations; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Forced Expiratory Volume; Humans; Male; Metered Dose Inhalers; Middle Aged; Salmeterol Xinafoate; Single-Blind Method; Theophylline; Treatment Outcome | 2005 |
A comparison between inhaled salmeterol and theophylline in the short-term treatment of stable chronic obstructive pulmonary disease.
Topics: Administration, Inhalation; Aged; Albuterol; Bronchodilator Agents; Cross-Over Studies; Delayed-Action Preparations; Dose-Response Relationship, Drug; Double-Blind Method; Female; Forced Expiratory Volume; Glucocorticoids; Humans; Male; Middle Aged; Peak Expiratory Flow Rate; Prednisone; Pulmonary Disease, Chronic Obstructive; Salmeterol Xinafoate; Theophylline; Treatment Outcome; Vital Capacity | 2005 |
Effects of salmeterol in patients with persistent asthma receiving inhaled corticosteroid plus theophylline.
Topics: Administration, Inhalation; Adrenal Cortex Hormones; Adult; Aged; Albuterol; Asthma; Bronchodilator Agents; Cross-Over Studies; Dose-Response Relationship, Drug; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Salmeterol Xinafoate; Theophylline; Treatment Outcome | 2007 |
Comparison of salmeterol/fluticasone propionate (FP) combination with FP+sustained release theophylline in moderate asthma patients.
Topics: Administration, Inhalation; Adult; Aged; Albuterol; Androstadienes; Asthma; Bronchodilator Agents; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Female; Fluticasone; Forced Expiratory Volume; Humans; Japan; Male; Middle Aged; Salmeterol Xinafoate; Theophylline; Treatment Outcome | 2008 |
Cost effectiveness of therapy with combinations of long acting bronchodilators and inhaled steroids for treatment of COPD.
Topics: Administration, Inhalation; Albuterol; Androstadienes; Bronchodilator Agents; Cost-Benefit Analysis; Delayed-Action Preparations; Drug Combinations; Fluticasone; Humans; Prospective Studies; Pulmonary Disease, Chronic Obstructive; Quality-Adjusted Life Years; Salmeterol Xinafoate; Scopolamine Derivatives; Theophylline; Tiotropium Bromide | 2008 |
Effects of bronchodilators on regional lung sound distribution in patients with chronic obstructive pulmonary disease.
Topics: Adult; Aged; Aged, 80 and over; Albuterol; Bronchodilator Agents; Cross-Over Studies; Double-Blind Method; Female; Humans; Lung; Male; Middle Aged; Pulmonary Disease, Chronic Obstructive; Respiratory Sounds; Salmeterol Xinafoate; Scopolamine Derivatives; Theophylline; Tiotropium Bromide; Tomography, X-Ray Computed; Vibration | 2014 |
23 other study(ies) available for theophylline and salmeterol xinafoate
Article | Year |
---|---|
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration | 2004 |
Chemical genetics reveals a complex functional ground state of neural stem cells.
Topics: Animals; Cell Survival; Cells, Cultured; Mice; Molecular Structure; Neoplasms; Neurons; Pharmaceutical Preparations; Sensitivity and Specificity; Stem Cells | 2007 |
Multi-target spectral moment QSAR versus ANN for antiparasitic drugs against different parasite species.
Topics: Antiparasitic Agents; Molecular Structure; Neural Networks, Computer; Parasitic Diseases; Quantitative Structure-Activity Relationship; Species Specificity; Thermodynamics | 2010 |
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
The aliphatic oxidation of salmeterol to alpha-hydroxysalmeterol in human liver microsomes is catalyzed by CYP3A.
Topics: Adrenergic beta-Agonists; Albuterol; Biomarkers; Chromatography, High Pressure Liquid; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Disulfiram; Humans; Isoenzymes; Ketoconazole; Microsomes, Liver; Midazolam; Molecular Structure; Oxidation-Reduction; Quinidine; Recombinant Proteins; Salmeterol Xinafoate; Sulfaphenazole; Theophylline | 1996 |
Drug use and pulmonary death rates in increasingly symptomatic asthma patients in the UK.
Topics: Adolescent; Adrenergic beta-Agonists; Adult; Albuterol; Asthma; Bronchodilator Agents; Case-Control Studies; Child; Chronic Disease; Cohort Studies; Databases, Factual; Family Practice; Female; Humans; Ipratropium; Male; Middle Aged; Risk; Salmeterol Xinafoate; Theophylline; United Kingdom | 1997 |
The effects of bronchodilators on spontaneous ventilation and oxygen consumption in rhesus monkeys.
Topics: Adrenergic beta-Agonists; Albuterol; Analysis of Variance; Animals; Bronchodilator Agents; Drug Evaluation, Preclinical; Ethanolamines; Fenoterol; Formoterol Fumarate; Infusions, Intravenous; Ipratropium; Macaca mulatta; Male; Oxygen Consumption; Pulmonary Ventilation; Salmeterol Xinafoate; Theophylline | 1997 |
Risk of emergency care, hospitalization, and ICU stays for acute asthma among recipients of salmeterol.
Topics: Adolescent; Adrenergic beta-Agonists; Adult; Age Factors; Albuterol; Anti-Asthmatic Agents; Asthma; Bronchodilator Agents; Confidence Intervals; Critical Care; Delayed-Action Preparations; Emergency Service, Hospital; Female; Follow-Up Studies; Hospitalization; Humans; Incidence; Lung Diseases, Obstructive; Male; Middle Aged; New England; Odds Ratio; Records; Risk Factors; Salmeterol Xinafoate; Sex Factors; Theophylline | 1998 |
Glucocorticoid receptors in bronchial epithelial cells in asthma.
Topics: Administration, Oral; Adult; Aged; Albuterol; Anti-Inflammatory Agents; Asthma; Biopsy; Bronchi; Bronchitis; Bronchodilator Agents; Budesonide; Chronic Disease; Epithelial Cells; Gene Expression Regulation; Glucocorticoids; Granulocyte-Macrophage Colony-Stimulating Factor; HSP90 Heat-Shock Proteins; Humans; Intercellular Adhesion Molecule-1; Middle Aged; Prednisone; Proteins; Receptors, Glucocorticoid; RNA, Messenger; Salmeterol Xinafoate; Theophylline | 1998 |
Drugs for asthma.
Topics: Acetates; Administration, Inhalation; Administration, Oral; Adolescent; Adrenal Cortex Hormones; Adrenergic beta-Agonists; Adult; Aged; Albuterol; Asthma; Bone Density; Bronchial Spasm; Bronchodilator Agents; Child; Child, Preschool; Choice Behavior; Cromolyn Sodium; Cyclopropanes; Exercise; Female; Growth; Humans; Hydroxyurea; Indoles; Infant, Newborn; Ipratropium; Lactation; Leukotriene Antagonists; Phenylcarbamates; Pregnancy; Pregnancy Complications; Quinolines; Salmeterol Xinafoate; Sulfides; Sulfonamides; Tachycardia; Theophylline; Tosyl Compounds | 1999 |
Effects of interleukin-10 and modulators of cyclic AMP formation on endotoxin-induced inflammation in rat lung.
Topics: Administration, Inhalation; Adrenergic beta-Agonists; Albuterol; Animals; Bronchoalveolar Lavage Fluid; Bucladesine; Cell Count; Cyclic AMP; Dose-Response Relationship, Drug; Endotoxins; Free Radical Scavengers; Inflammation; Interleukin-10; Lipopolysaccharides; Luminescent Measurements; Luminol; Lung; Male; Neutrophils; Phosphodiesterase Inhibitors; Pyrrolidinones; Rats; Rats, Wistar; Rolipram; Salmeterol Xinafoate; Superoxide Dismutase; Theophylline; Tumor Necrosis Factor-alpha; Zymosan | 1999 |
Inhaled corticosteroid therapy in asthma: a balancing act.
Topics: Administration, Inhalation; Adrenal Cortex Hormones; Adrenergic beta-Agonists; Albuterol; Androstadienes; Anti-Asthmatic Agents; Asthma; Beclomethasone; Bronchodilator Agents; Child; Drug Resistance; Drug Therapy, Combination; Ethanolamines; Fluticasone; Forced Expiratory Volume; Formoterol Fumarate; Humans; Leukotriene Antagonists; Salmeterol Xinafoate; Theophylline | 1999 |
Drugs for asthma.
Topics: Acetates; Administration, Inhalation; Administration, Oral; Adrenal Cortex Hormones; Adrenergic beta-2 Receptor Agonists; Adrenergic beta-Agonists; Adult; Albuterol; Asthma; Bronchial Spasm; Child; Cromolyn Sodium; Cyclopropanes; Exercise; Female; Growth Disorders; Humans; Hydroxyurea; Indoles; Ipratropium; Lactation; Leukotriene Antagonists; Nebulizers and Vaporizers; Nedocromil; Phenylcarbamates; Pregnancy; Pregnancy Complications; Quinolines; Salmeterol Xinafoate; Sulfides; Sulfonamides; Theophylline; Tosyl Compounds | 2000 |
Practical pharmacotherapy for pediatric asthma.
Topics: Albuterol; Asthma; Asthma, Exercise-Induced; Bronchodilator Agents; Budesonide; Child; Glucocorticoids; Humans; Leukotrienes; Salmeterol Xinafoate; Theophylline | 2000 |
Effects of glucocorticoids on endogenous and transcellular metabolism of eicosanoids in asthma.
Topics: 5-Lipoxygenase-Activating Proteins; Administration, Inhalation; Administration, Oral; Adrenergic beta-Antagonists; Adult; Albuterol; Anti-Asthmatic Agents; Anti-Inflammatory Agents; Arachidonate 5-Lipoxygenase; Arachidonic Acids; Asthma; Beclomethasone; Calcimycin; Calcium; Carrier Proteins; Chromatography, High Pressure Liquid; Drug Therapy, Combination; Eicosanoids; Female; Humans; Ionophores; Male; Membrane Lipids; Membrane Proteins; Methylprednisolone; Neutrophils; Phospholipids; Prednisone; Salmeterol Xinafoate; Theophylline | 2001 |
Optimizing bronchodilator therapy for copd.
Topics: Albuterol; Bronchodilator Agents; Humans; Lung Diseases, Obstructive; Salmeterol Xinafoate; Theophylline | 2001 |
Regulation of mediator secretion in human basophils by p38 mitogen-activated protein kinase: phosphorylation is sensitive to the effects of phosphatidylinositol 3-kinase inhibitors and calcium mobilization.
Topics: Albuterol; Basophils; Calcimycin; Calcium Channel Blockers; Calcium Signaling; Calcium-Calmodulin-Dependent Protein Kinases; Chromones; Cyclic AMP; Enzyme Activation; Enzyme Inhibitors; Flavonoids; Histamine Release; Humans; Imidazoles; Immunoglobulin E; Interleukin-13; Interleukin-4; Interleukins; Leukotriene C4; MAP Kinase Kinase 3; MAP Kinase Kinase 6; MAP Kinase Signaling System; Mitogen-Activated Protein Kinase Kinases; Mitogen-Activated Protein Kinases; Morpholines; N-Formylmethionine Leucyl-Phenylalanine; p38 Mitogen-Activated Protein Kinases; Phosphatidylinositol 3-Kinases; Phosphoinositide-3 Kinase Inhibitors; Phosphorylation; Protein Processing, Post-Translational; Protein-Tyrosine Kinases; Pyridines; Salmeterol Xinafoate; Second Messenger Systems; Theophylline | 2002 |
Retrospective analysis of adverse drug reactions to bronchodilators observed in two pulmonary divisions of Catanzaro, Italy.
Topics: Administration, Inhalation; Adolescent; Adult; Aged; Albuterol; Beclomethasone; Bronchodilator Agents; Child; Child, Preschool; Ethanolamines; Female; Formoterol Fumarate; Hospitalization; Humans; Infant; Italy; Logistic Models; Lung Diseases; Male; Middle Aged; Retrospective Studies; Salmeterol Xinafoate; Theophylline | 2003 |
Combined salmeterol and fluticasone for COPD.
Topics: Administration, Inhalation; Albuterol; Androstadienes; Bronchodilator Agents; Cholinergic Antagonists; Drug Therapy, Combination; Fluticasone; Humans; Pulmonary Disease, Chronic Obstructive; Salmeterol Xinafoate; Theophylline; Vital Capacity | 2003 |
Prescribing for asthmatic children in primary care. Are we following guidelines?
Topics: Adolescent; Adrenergic beta-Agonists; Albuterol; Asthma; Bronchodilator Agents; Child; Child, Preschool; Female; Guideline Adherence; Humans; Infant; Male; Practice Guidelines as Topic; Practice Patterns, Physicians'; Salmeterol Xinafoate; Saudi Arabia; Theophylline | 2003 |
The value of early diagnosis for effective management of chronic obstructive pulmonary disease.
Topics: Adrenal Cortex Hormones; Albuterol; Androstadienes; Bronchodilator Agents; Cholinergic Antagonists; Drug Therapy, Combination; Early Diagnosis; Fluticasone; Health Education; Humans; Influenza Vaccines; Pneumococcal Vaccines; Pneumonectomy; Pulmonary Disease, Chronic Obstructive; Risk Factors; Salmeterol Xinafoate; Scopolamine Derivatives; Severity of Illness Index; Smoking; Spirometry; Surveys and Questionnaires; Survival Analysis; Theophylline; Tiotropium Bromide; Treatment Outcome | 2007 |
Regression of giant bullous emphysema.
Topics: Administration, Inhalation; Albuterol; Asthma; Bronchodilator Agents; Drug Therapy, Combination; Humans; Lung, Hyperlucent; Male; Middle Aged; Remission Induction; Salmeterol Xinafoate; Theophylline; Tomography, X-Ray Computed | 2010 |
Effects of β₂-agonists on force during and following anoxia in rat extensor digitorum longus muscle.
Topics: Adrenergic beta-2 Receptor Agonists; Albuterol; Animals; Bucladesine; Deoxyglucose; Electric Stimulation; Female; Glycolysis; Hypoxia; Male; Membrane Potentials; Muscle Contraction; Muscle Fatigue; Muscle, Skeletal; Ouabain; Potassium; Rats; Rats, Wistar; Salmeterol Xinafoate; Sodium; Sodium-Potassium-Exchanging ATPase; Terbutaline; Theophylline | 2012 |